Abstract
In the version of this article initially published, the source of lonafarnib was not provided. This should be included as the second sentence of the Acknowledgements section, as follows: “Lonafarnib was provided by Merck through The Progeria Research Foundation’s Pre-Clinical Drug Supply Program.” The error has been corrected in the HTML and PDF versions of the article.
Cite
CITATION STYLE
Puttaraju, M., Jackson, M., Klein, S., Shilo, A., Bennett, C. F., Gordon, L., … Misteli, T. (2021, July 1). Author Correction: Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson–Gilford progeria syndrome (Nature Medicine, (2021), 27, 3, (526-535), 10.1038/s41591-021-01262-4). Nature Medicine. Nature Research. https://doi.org/10.1038/s41591-021-01415-5
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
